Search

everythinglearnresearchcommunity

for

Search:↓

JAK inhibitors may effectively treat lichen planopilaris and frontal fibrosing alopecia with minimal side effects.

Terbinafine effectively treated kerion celsi despite disrupted immune responses.

The treatment significantly improved lymphocytic cicatricial alopecia symptoms in most patients.

Dupilumab can both trigger and treat alopecia areata, often leading to hair regrowth.

JAK inhibitors show promise for treating alopecia areata but have serious side effects.

Baricitinib can help improve hair loss and skin color issues in people with Down syndrome.

A girl with Crohn's disease developed hair loss due to her increased medication, a rare side effect seen in some children.

Guselkumab effectively reduces fatigue in Psoriatic Arthritis patients over two years.

Tofacitinib may be safe and effective for treating certain skin conditions in children.

Uveal melanoma is hard to treat when it spreads, but a new drug, tebentafusp, helps patients live longer.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

Dupilumab can both cause and treat alopecia areata, with many patients experiencing hair regrowth.

Oral tofacitinib can treat both psoriasis and alopecia universalis by normalizing inflammatory pathways.

Intravenous methylprednisolone helped over half of alopecia areata patients regrow hair, but many relapsed.

New treatments are making advanced prostate cancer management more complex but also more hopeful.

Colectomy led to hair regrowth in a Crohn's patient with alopecia areata.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

The combination therapy is effective and well-tolerated for treating esophageal cancer.

Methotrexate treatment for rheumatoid arthritis has a serious infection rate of about two per 100 patient-years.

Human dermal fibroblasts are the main cells targeted by a virus that can cause a deadly skin cancer, and a certain inhibitor can effectively block this infection.

Ritlecitinib may cause severe musculoskeletal pain in some alopecia universalis patients.

Janus kinase inhibitors may effectively treat resistant scalp conditions like folliculitis decalvans and dissecting cellulitis.

Ruxolitinib cream effectively treats skin conditions like atopic dermatitis and vitiligo with minimal side effects.

JAK inhibitors may help treat alopecia areata and promote hair regrowth.

Ritlecitinib improves emotional well-being and activity levels in alopecia areata patients.

Ritlecitinib improves hair regrowth in alopecia areata over 24 months.

Abrocitinib is being evaluated for safety and effectiveness in treating moderate to severe atopic dermatitis.

Abrocitinib helped a 14-year-old girl with severe alopecia areata regrow her hair significantly.

Tofacitinib effectively improved hair regrowth and skin condition in a woman with alopecia totalis and lichen planus hypertrophicus.